Cargando…
Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, pleural effusion, fever, renal dysfunction, reticulin fibrosis of the bone marrow, and organomegaly. The clinical course varies significantly among patients. However, the prognosis is usually dismal in patients...
Autores principales: | Kikuchi, Taku, Shimizu, Takayuki, Toyama, Takaaki, Abe, Ryohei, Okamoto, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596285/ https://www.ncbi.nlm.nih.gov/pubmed/28781319 http://dx.doi.org/10.2169/internalmedicine.8522-16 |
Ejemplares similares
-
Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome
por: Tatekawa, Shotaro, et al.
Publicado: (2015) -
TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin
por: Takayama, Yusuke, et al.
Publicado: (2017) -
Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure
por: Aoki, Tatsuya, et al.
Publicado: (2017) -
Stepwise Treatment for TAFRO Syndrome
por: Ide, Makoto, et al.
Publicado: (2023) -
An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
por: Sakashita, Kentaro, et al.
Publicado: (2016)